Evelyn Fricke

Title: Evelyn Fricke: Innovator in Nucleic Acid Immobilization

Introduction

Evelyn Fricke is a notable inventor based in Hilden, Germany. She has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid immobilization. With a total of 2 patents to her name, her work has implications for various applications in biotechnology and research.

Latest Patents

Evelyn Fricke's latest patents include innovative methods for immobilizing nucleic acid molecules on solid supports. The first patent describes a method for immobilizing a nucleic acid molecule on solid support, emphasizing the use of a non-immobilized primer in combination with a nucleic acid primer linked to a solid support. The second patent also focuses on a method for immobilizing a nucleic acid molecule on a solid support, detailing the use of a combination of a first nucleic acid immobilized primer and a second immobilized primer linked to the solid support.

Career Highlights

Evelyn Fricke is currently employed at Qiagen GmbH, a leading company in the field of molecular diagnostics and sample preparation. Her work at Qiagen has allowed her to further develop her innovative ideas and contribute to advancements in biotechnology.

Collaborations

Evelyn collaborates with her coworker, Christian Korfhage, to enhance the research and development efforts at Qiagen GmbH. Their combined expertise fosters a productive environment for innovation.

Conclusion

Evelyn Fricke's contributions to the field of nucleic acid immobilization demonstrate her commitment to advancing biotechnology. Her patents reflect her innovative spirit and dedication to scientific progress.